Tackling IUD Insertion Pain with Aspivix
IUD insertions are painful, but they shouldn’t have to be. Join us as we talk to Ikram Guerd, VP of Marketing at Aspivix to learn more about how their innovative devices are taking a stand against pain in gynecological care. In their conversation, Ikram and Brittany discuss the current tools used in procedures that pass the cervix, why pain is so commonly accepted in women’s health, and how patients and physicians can request the Aspivix Carevix for their procedures.
LATEST EPISODE
A podcast about innovation in women’s health.
Recent Episodes
-

From Lab to Market: Ovarian Cancer Diagnostic Innovation with Aspira Women’s Health
Episode 229
-

VCs for Repro: Abortion is Your Business
Episode 228
-

Coroflo Measures What Matters: Quantifying Breast Milk
Episode 227
-

Decoding the Vaginal Microbiome
Episode 226
-

Getting to Know Your Vagina
Episode 225
-

2023 End of Year Review
Episode 224
Subscribe to our weekly newsletter for the latest episodes & femtech insights.
Meet Your Host,
Dr. Brittany Barreto
Dr. Brittany Barreto is a trailblazer in the field of FemTech, using her scientific background, entrepreneurial spirit, and investment expertise to raise awareness of women’s health issues and showcase the importance of this vital industry.
Dr. Barreto is a proud advocate of FemTech founders and the FemTech Focus podcast is a space for honest and thought-provoking conversations about the past, present, and future of female health. Informative, shocking, and candid, this podcast exposes the truth about the status of female health globally and brings to light the opportunities and current innovations striving to achieve health equality.
Founder Community
FemHealth Insights is home to a thriving global community of 1k+ innovators in female health.
Join today and make connections with experienced entrepreneurs, learn how to get investment deals, and gain free access to the FemHealth Insights database to stack your pitch deck with comparables, explore successful business models, and more.